Smith & Howard Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,407
Closed -$224K 73
2022
Q4
$224K Buy
2,407
+105
+5% +$10.1K 0.09% 64
2022
Q3
$220K Buy
+2,302
New +$228K 0.09% 59
2022
Q2
Sell
-2,049
Closed -$207K 68
2022
Q1
$207K Sell
2,049
-25
-1% -$2.63K 0.09% 68
2021
Q4
$214K Buy
+2,074
New +$192K 0.1% 68
2014
Q1
Sell
-100
Closed -$7K 78
2013
Q4
$7K Sell
100
-1,600
-94% -$103K ﹤0.01% 212
2013
Q3
$96K Hold
1,700
0.06% 76
2013
Q2
$97K Buy
+1,700
New +$98.5K 0.06% 68

Other funds holding CVS

Smith & Howard Wealth Management's CVS Position: Q1 2023 in Review

Smith & Howard Wealth Management sold out of CVS Health (CVS) in Q1 2023, closing a stake of 2,407 shares — an estimated $224K sold.

Smith & Howard Wealth Management first reported a position in CVS in Q2 2013 and held it in 7 quarters. The position peaked at $224K in Q4 2022. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • Smith & Howard Wealth Management reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
  • Smith & Howard Wealth Management sold 2,407 CVS Health shares in Q1 2023, an estimated $224K.
  • Smith & Howard Wealth Management first reported a position in CVS Health in Q2 2013 and held it in 7 quarters.
  • Smith & Howard Wealth Management's CVS Health position peaked at $224K in Q4 2022.
  • 2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Smith & Howard Wealth Management's 13F filing for Q1 2023, filed 13 Apr 2023.